Abstract
This chapter is an introduction to the biology of reactive oxygen species (ROS) in the brain. In healthy aerobes, there is a balance between the production of various ROS and antioxidant defenses. Living organisms have not only adapted to coexistence with free radicals but have developed various mechanisms for the advantageous use of free radicals in various physiological functions. Infectious diseases were a powerful driver of natural selection in early human civilizations. Indeed, ROS participate directly in defense against infection. In a normal situation, microglia, which are resident macrophages of the brain, fight against infection by ROS. ROS are well recognized for playing a dual role, having both deleterious and beneficial effects, which in most cases depend on concentration. At high ROS concentrations there are harmful effects, and in a low–moderate concentration ROS are involved in physiological roles in cellular response to noxious stimuli. It was suggested that the main effects of ROS on cells are through their actions on signaling pathways rather than causing nonspecific damage. With aging, when these pathways deteriorate, accumulation of higher concentrations of ROS occurs in amounts beyond the capacity of antioxidants to cope. This deterioration results in the age-associated neurodegenerative disorders such as stroke and central nervous system (CNS) trauma as well as Parkinson’s and Alzheimer’s disease. Some of the CNS-evolved specific signaling pathways are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Halliwell B, Gutteridge JMC. Free radicals in biology and medicine,. 4th edn. Oxford University Press, Oxford, 2007.
Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem.. 2006;97:1634–58.
Nohl H, Hegner D. Do mitochondria produce oxygen free radicals in vivo? Eur J Biochem. 1978;82:563–7.
Sohal RS. Mitochondria generate superoxide anion radicals and hydrogen peroxide. FASEB J. 1997;11:1269–70.
Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem. 1989;264:7761–4.
Touati D. The molecular genetics of superoxide dismutase in E. coli. An approach to understanding the biological role and regulation of SOD in relation to other elements of the defense system against oxygen toxicity. Free Radic Biol Med. 1989;8:1–9.
Imlay JA, Chin SM, Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science. 1988;240:1302–9.
Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1–85.
Yamazaki I, Piette LH. EPR spin trapping study on the oxidizing species formed in the reaction of the ferrous ion with hydrogen peroxide. J Am Chem Soc. 1991;113:7588–93.
Jain A, Martensson J, Stole E, et al. Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA. 1991;88:1913–7.
Cochrane CG. Mechanisms of oxidant injury of cells. Mol Aspects Med. 1991;12:137–47.
Halliwell B, Aruoma OI. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 1991;28:9–19.
Orrenius S, McConkey DJ, Bellomo G, et al. Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci. 1989;10:281–5.
Asano T, Matsui T, Takuwa Y. Lipid peroxidation, protein kinase C and cerebral ischemia. Crit Rev Neurosurg. 1991;1:361–79.
Sevanian A, McLeod LL. Formation and biological reactivity of lipid peroxidation. In: Wallace KB, editors. Free radical toxicology. Washington, DC, Taylor & Francis, 1997:47–70.
Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244–50.
Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys. 1992;298:438–55.
Crow JP, Beckman NJS, McCord JM. Sensitivity of the zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and perxoinitrite. Biochemistry. 1995;34:3544–52.
Radi R, Beckman JS, Bush KM, et al. Peroxynitrite induced membrane lipid peroxidation. The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:81–7.
Moreno JJ, Pryor WA. Inactivation of alpha 1-proteinase inhibitor by peroxynitrite. Chem Res Toxic. 1992;5:425–31.
Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120:437–47.
Maher P, Schubert D. Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci. 2000;57:1287–305.
Sugawara T, Fujimura M, Noshita N, et al. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx. 2004;1:17–25.
Maher P. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci. 2001;21:2929–38.
Kamada H, Nito C, Endo H, et al. Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2006;27:521–33.
Adibhatla RM, Hatcher JF, Dempsey RJ. Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem. 2002;80:12–23.
Saeed SA, Shad KF, Saleem T, et al. Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res. 2007;182:1–10.
Taylor JM, Crack PJ. Impact of oxidative stress on neuronal survival. Clin Exp Pharmacol Physiol. 2004;31:397–406.
Hewett SJ, Uliasz TF, Vidwans AS, et al. Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther. 2000;293:417–25.
Toescu EC. Hypoxia sensing and pathways of cytosolic Ca2+ increases. Cell Calcium. 2004;36:187–99.
Chen RM, Chen TL, Chiu WT, et al. Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res. 2005;23:462–8.
Maines MD. The heme oxygenase system: update. Antioxid Redox Signal. 2005;7:1761–6.
Poon HF, Calabrese V, Scapagnini G, et al. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci. 2004;59:478–93.
Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des. 2003;9:2499–511.
Franklin TB, Krueger-Naug AM, Clarke DB, et al. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia. 2005;21:379–92.
Igarashi K, Sun J. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal. 2006;8:107–18.
Calabrese V, Guagliano E, Sapienza M, et al. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res. 2007;32:757–73.
Gilgun-Sherki Y, Rosenbaum Z, Melamed E et al. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev. 2002;54:271–84.
Williams AJ, Berti R, Dave JR, et al. Delayed treatment of ischemia/reperfusion brain injury: Stroke. 2004;35:1186–91.
Van der Worp HB, Bar PR, Kappelle LJ, et al. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats. Stroke. 1998;29:1002–5.
Asai A, Tanahashi N, Qiu JH, et al. Selective proteasomal dysfunction in the hippocampal CA1 region after transient forebrain ischemia. J Cereb Blood Flow Metab. 2002;22:705–10.
Bayir H, Marion DW, Puccio AM, et al. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma. 2004;21:1–8.
Ballabh P, Braun A, Nedergaard M. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1–13.
Phillis JW, O’Regan MH. A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res Rev. 2004;44:13–47.
Liu D, Liu J, Sun D, et al. Spinal cord injury increases iron levels: catalytic production of hydroxyl radicals. Free Radic Biol Med. 2003;34:64–71.
Macdonald RL, Marton LS, Andrus PK, et al. Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci. 2004;75:979–89.
Wagner KR, Sharp FR, Ardizzone TD, et al. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab. 2003;23:629–59.
Chang EF, Wong RJ, Vreman HJ, et al. Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci. 2003;23:3689–96.
Berg D, Youdim MB, Riederer P. Redox imbalance. Cell Tissue Res. 2004;318:201–13.
Cui K, Luo X, Xu K, et al. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuro-psychopharmacol Biol Psychiatry. 2004;28:771–99.
Fato R, Bergamini C, Leoni S, et al. Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration. Neurochem Res. 2008;33:2487–501.
Uversky VN. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004;318:225–41.
Bove J, Prou D, Perier C, et al. Toxin-induced models of Parkinson’s disease. NeuroRx. 2005;2:484–94.
Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215–24.
Wersinger C, Sidhu A. An inflammatory pathomechanism for Parkinson’s disease? Curr Med Chem. 2006;13:591–602.
Landrigan PJ, Sonawane B, Butler RN, et al. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect. 2005;113:1230–3.
Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson’s disease? Brain Res Mol Brain Res. 2005;134:18–23.
Kotake Y, Ohta S. MPP+ analogs acting on mitochondria and inducing neuro-degeneration. Curr Med Chem. 2003;10:2507–16.
Shimizu K, Matsubara K, Ohtaki K, et al. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci Res. 2003;46:523–32.
Peng J, Stevenson FF, Doctrow SR, et al. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J Biol Chem. 2005;280:2194–8.
Yang W, Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health Part A. 2005;68:1939–61.
Thiruchelvam M, Prokopenko O, Cory-Slechta DA, et al. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem. 2005;280:22530–9.
Shimizu K, Matsubara K, Ohtaki K, et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res. 2003;976:243–52.
Bretaud S, Lee S, Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson’s disease. Neurotoxicol Teratol. 2004;26:857–64.
Chun HS, Gibson GE, DeGiorgio LA, et al. Dopaminergic cell death induced by MPP (+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem. 2001;76:1010–21.
Block ML, Li G, Qin L, et al. Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J. 2006;20:251–8.
Li J, Baud O, Vartanian T, et al. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA. 2005;102:9936–41.
Zhang W, Wang T, Pei Z, et al. aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J. 2005;19:533–42.
Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal. 2005;7:1223–33.
Scheller C, Sopper S, Jenuwein M, et al. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem. 2005;95:377–87.
Gao HM, Hong JS, Zhang W, et al. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 2002;22:782–90.
Casarejos MJ, Menendez J, Solano RM, et al. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem. 2006;97:934–46.
Croisier E, Moran LB, Dexter DT, et al. Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J Neuroinflammation. 2005;2:14–22.
Miller RL, James-Kracke M, Sun GY, et al. Oxidative and inflammatory pathways in Parkinson’s disease. Neurochem Res. 2009;34:55–65.
Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med. 1997;23:134–47.
Zhu X, Smith MA, Perry G, et al. Mitochondrial failures in Alzheimer’s disease. Am J Alzheimer’s Dis Other Demen. 2004;19:345–52.
Block ML. NADPH oxidase as a therapeutic target in Alzheimer’s disease. BMC Neurosci. 2008;9:S8.
Friedlich AL, Butcher LL. Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis. Neurobiol Aging. 1994;15:443–55.
Hashimoto M, Rockenstein E, Crews L, et al. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med. 2003;4:21–36.
Dyrks T, Dyrks E, Hartmann T, et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem. 1992;267:18210–7.
Hensley K, Carney J, Hall N, et al. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radic Biol Med. 1994;17:321–31.
Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994;77:817–27.
Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Disc. 2004;3:205–14.
Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci. 2004;24:565–75.
Pappolla MA, Sos M, Omar RA, et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci. 1997;17:1683–90.
Reiter RJ. The ageing pineal gland and its physiological consequences. Bio Essays. 1992;14:169–75.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Friedman, J. (2011). The Role of Free Radicals in the Nervous System. In: Gadoth, N., Göbel, H. (eds) Oxidative Stress and Free Radical Damage in Neurology. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-60327-514-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-60327-514-9_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-513-2
Online ISBN: 978-1-60327-514-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)